Page 20 - Biomedical Sciences News Today

The five-year study aims to identify more effective treatments.

Climate change will drive new transmission of 4,000 viruses between mammals by 2070 : Rashtra News #Climate #change #drive #transmission #viruses #mammals Blaise Kadjo, a specialist in mammals and a professor at the Felix Houphouet-Boigny University, shows a species of bat in the researcg laboratary of the zoology and animal biology depertment at the University

Private equity’s foray into the human health care have been blamed for increasing prices, slashing services and shuttering hospitals to maximize profits -- and veterinarians say the pet health care industry could see similar results.

In its Best Graduate Schools ranking, the publication placed 10 of Texas A&M’s graduate programs in the Top 20; among those, six are Top 10.

(FOX40.COM) — The first total solar eclipse since 2017 is expected to return on Monday and while many people are fascinated about the moon covering the sun, pets and wildlife may not be too thrilled. Video Above: How do animals react to a solar eclipse? The eclipse is expected to spread above 15 states, Mexico, […]

Talal highlights the use of facilitated telemedicine for increasing access to HCV treatment and other areas it might expand access for underserved patient populations.

Experts from around the country present the science behind elevating beef operations.

Synchron Inc, a rival to Elon Musks Neuralink brain implant startup, is preparing to recruit patients for a large-scale clinical trial required to seek commercial approval for its device, the...

Synchron Inc, a rival to Elon Musk's Neuralink brain implant startup, is preparing to recruit patients for a large-scale clinical trial required to seek commercial approval for its device, the company's chief executive told Reuters. Synchron on Monday plans to launch an online registry for patients interested in joining the trial meant to include dozens of participants, and has received interest from about 120 clinical trial centers to help run the study, CEO Thomas Oxley said in an i...

Synchron plans to launch an online registry for patients interested in joining the trial